What is the recommended treatment for Loeffler syndrome with intestinal ascariasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Loeffler Syndrome with Intestinal Ascariasis

For Loeffler syndrome caused by Ascaris lumbricoides, treat with albendazole 400 mg twice daily for 3 days, and consider adding prednisolone 30 mg daily for 5 days in severe cases to reduce symptom duration. 1

Treatment Algorithm

First-Line Anthelmintic Therapy

Albendazole is the preferred agent for treating both the pulmonary (Loeffler syndrome) and intestinal phases of ascariasis:

  • Albendazole 400 mg twice daily for 3 days is recommended during the acute pulmonary phase (Loeffler syndrome) 1
  • After the acute phase resolves, albendazole 400 mg as a single dose effectively treats intestinal ascariasis 2, 1, 3
  • Alternative single-dose regimens include mebendazole 500 mg once or ivermectin 200 μg/kg once 3

Corticosteroid Therapy for Severe Cases

  • Prednisolone 30 mg daily for 5 days may reduce symptom duration in patients with severe respiratory symptoms (fever, significant cough, wheezing, hemoptysis) 1
  • This is based on expert opinion and should be reserved for symptomatic relief in moderate-to-severe cases 1

Alternative Regimens

If albendazole alone is insufficient or you want broader empirical coverage (particularly if strongyloidiasis cannot be excluded):

  • Albendazole 400 mg twice daily for 3 days PLUS ivermectin 200 μg/kg once daily for 3 days provides comprehensive coverage 1
  • Mebendazole 100 mg twice daily for 3 days is an alternative to albendazole 1, 4

Critical Clinical Considerations

Timing of Treatment

  • Loeffler syndrome occurs during the prepatent period (1-2 weeks post-infection) when larvae migrate through the lungs 1
  • Stool microscopy may still be negative during this acute phase, so treatment should be empirical based on clinical presentation 1
  • Repeat stool examination 3-4 weeks after initial symptoms to confirm intestinal infection and treatment success 3

Important Caveats

Do NOT use corticosteroids if strongyloidiasis is suspected, as steroids can precipitate life-threatening hyperinfection syndrome with Strongyloides stercoralis 1. Key distinguishing features:

  • Strongyloides causes larva currens (rapidly migrating urticarial tracks) which Ascaris does not 2
  • If there is any doubt about the causative organism, add ivermectin to the regimen rather than using steroids alone 1
  • Strongyloides requires more aggressive treatment: ivermectin 200 μg/kg on days 1,2,15, and 16 in immunocompromised patients 1

Diagnostic Confirmation

While treatment is often empirical during acute Loeffler syndrome:

  • Concentrated stool microscopy remains the gold standard once the intestinal phase begins 2, 3
  • Look for migratory pulmonary infiltrates on chest X-ray and peripheral eosinophilia to support the diagnosis 1, 5
  • Rarely, larvae may be visible in sputum or bronchoalveolar lavage during the pulmonary phase 1, 5
  • Adult worms passed in stool (earthworm-sized, white/pink) confirm ascariasis 2, 3

Expected Outcomes

  • Cure rates exceed 95% with appropriate anthelmintic therapy 6
  • Respiratory symptoms typically resolve within days to weeks with treatment 7
  • Radiographic infiltrates should resolve within 1 month of treatment 8
  • No special procedures (fasting, purging) are required 4

Special Populations

  • Pregnancy: Use pyrantel pamoate instead of albendazole or mebendazole 6
  • Children: Same dosing as adults for albendazole and mebendazole 4
  • Immunocompromised patients: Require specialist consultation, particularly if strongyloidiasis is possible 1

References

Guideline

Treatment of Loeffler's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Ascaris Lumbricoides Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnóstico de Ascaridiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Human Ascariasis: An Updated Review.

Recent patents on inflammation & allergy drug discovery, 2020

Research

Ascariasis and hookworm.

Seminars in respiratory infections, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.